Cilostazol
Supplier:
Catalogue number:
10-1131-02
Size:
50 mg
Product is available in:
PDE3A inhibitor / Cilostazol is a clinically approved phosphodiesterase III (PDE3) inhibitor (IC50 = 0.2 µM) and anti-thrombotic agent. It inhibits platelet aggregation and is a direct arterial vasodilator.
Product Type:
Biochemicals & reagents
CAS Number:
73963-72-1
Reference:
Schror (2002) The pharmacology of cilostazol. Diabetes Obes.Metab. 4 S14
Storage Temperature:
RT
Additional Information:
TARGET: PDE (Phosphodiesterase) -- PATHWAY: Coagulation; cAMP / cGMP signaling